263 related articles for article (PubMed ID: 9855008)
21. Impact of adduct determination on the assessment of cancer susceptibility.
Bartsch H; Rojas M; Alexandrov K; Risch A
Recent Results Cancer Res; 1998; 154():86-96. PubMed ID: 10026994
[TBL] [Abstract][Full Text] [Related]
22. Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls.
Perera F; Mayer J; Jaretzki A; Hearne S; Brenner D; Young TL; Fischman HK; Grimes M; Grantham S; Tang MX
Cancer Res; 1989 Aug; 49(16):4446-51. PubMed ID: 2743334
[TBL] [Abstract][Full Text] [Related]
23. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls.
Chen SY; Wang LY; Lunn RM; Tsai WY; Lee PH; Lee CS; Ahsan H; Zhang YJ; Chen CJ; Santella RM
Int J Cancer; 2002 May; 99(1):14-21. PubMed ID: 11948486
[TBL] [Abstract][Full Text] [Related]
24. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women.
Bennett WP; Alavanja MC; Blomeke B; Vähäkangas KH; Castrén K; Welsh JA; Bowman ED; Khan MA; Flieder DB; Harris CC
J Natl Cancer Inst; 1999 Dec; 91(23):2009-14. PubMed ID: 10580025
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Cooper J; Navidi WC; Carpenter CL; Idle JR
J Natl Cancer Inst; 1995 Aug; 87(16):1246-53. PubMed ID: 7563171
[TBL] [Abstract][Full Text] [Related]
26. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
27. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
[TBL] [Abstract][Full Text] [Related]
28. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
[TBL] [Abstract][Full Text] [Related]
29. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women.
Kiyohara C; Wakai K; Mikami H; Sido K; Ando M; Ohno Y
Int J Cancer; 2003 Oct; 107(1):139-44. PubMed ID: 12925969
[TBL] [Abstract][Full Text] [Related]
30. Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers.
Pavanello S; Pulliero A; Siwinska E; Mielzynska D; Clonfero E
Carcinogenesis; 2005 Jan; 26(1):169-75. PubMed ID: 15471894
[TBL] [Abstract][Full Text] [Related]
31. Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects.
Srám RJ
Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):231-9. PubMed ID: 9539016
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure.
Kihara M; Kihara M; Noda K
Carcinogenesis; 1994 Feb; 15(2):415-8. PubMed ID: 8313538
[TBL] [Abstract][Full Text] [Related]
33. GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients.
Hou SM; Ryberg D; Fält S; Deverill A; Tefre T; Børresen AL; Haugen A; Lambert B
Carcinogenesis; 2000 Jan; 21(1):49-54. PubMed ID: 10607733
[TBL] [Abstract][Full Text] [Related]
34. Influence of GSTM1 genotypes on anti-BPDE-DNA adduct levels in mononuclear white blood cells of humans exposed to PAH.
Pavanello S; Gabbani G; Mastrangelo G; Brugnone F; Maccacaro G; Clonfero E
Int Arch Occup Environ Health; 1999 Jul; 72(4):238-46. PubMed ID: 10491778
[TBL] [Abstract][Full Text] [Related]
35. Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans.
Ford JG; Li Y; O'Sullivan MM; Demopoulos R; Garte S; Taioli E; Brandt-Rauf PW
Carcinogenesis; 2000 Nov; 21(11):1971-5. PubMed ID: 11062156
[TBL] [Abstract][Full Text] [Related]
36. Influence of GSTM1 null and low repair XPC PAT+ on anti-B[a]PDE-DNA adduct in mononuclear white blood cells of subjects low exposed to PAHs through smoking and diet.
Pavanello S; Pulliero A; Clonfero E
Mutat Res; 2008 Feb; 638(1-2):195-204. PubMed ID: 18035379
[TBL] [Abstract][Full Text] [Related]
37. A cross-sectional study of polycyclic aromatic hydrocarbon-DNA adducts and polymorphism of glutathione S-transferases among heavy smokers by race/ethnicity.
Weiserbs KF; Jacobson JS; Begg MD; Wang LW; Wang Q; Agrawal M; Norkus EP; Young TL; Santella RM
Biomarkers; 2003; 8(2):142-55. PubMed ID: 12775499
[TBL] [Abstract][Full Text] [Related]
38. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: effects of glutathione S-transferase T1 and M1 genotypes.
Yong LC; Schulte PA; Wiencke JK; Boeniger MF; Connally LB; Walker JT; Whelan EA; Ward EM
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):539-50. PubMed ID: 11352866
[TBL] [Abstract][Full Text] [Related]
39. Environmental air pollution and DNA adducts in Copenhagen bus drivers--effect of GSTM1 and NAT2 genotypes on adduct levels.
Nielsen PS; de Pater N; Okkels H; Autrup H
Carcinogenesis; 1996 May; 17(5):1021-7. PubMed ID: 8640907
[TBL] [Abstract][Full Text] [Related]
40. The impact of glutathione s-transferase M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans.
Rothman N; Shields PG; Poirier MC; Harrington AM; Ford DP; Strickland PT
Mol Carcinog; 1995 Sep; 14(1):63-8. PubMed ID: 7546226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
